Skip to main content
Article thumbnail
Location of Repository

Interaction between CXCR4 and CCL20 Pathways Regulates Tumor Growth

By Katia Beider, Michal Abraham, Michal Begin, Hanna Wald, Ido D. Weiss, Ori Wald, Eli Pikarsky, Rinat Abramovitch, Evelyne Zeira, Eithan Galun, Arnon Nagler and Amnon Peled


The chemokine receptor CXCR4 and its ligand CXCL12 is overexpressed in the majority of tumors and is critically involved in the development and metastasis of these tumors. CXCR4 is expressed in malignant tumor cells whereas its ligand SDF-1 (CXCL12) is expressed mainly by cancer associated fibroblasts (CAF). Similarly to CXCR4, the chemokine CCL20 is overexpressed in variety of tumors; however its role and regulation in tumors is not fully clear. Here, we show that the chemokine receptor CXCR4 stimulates the production of the chemokine CCL20 and that CCL20 stimulates the proliferation and adhesion to collagen of various tumor cells. Furthermore, overexpression of CCL20 in tumor cells promotes growth and adhesion in vitro and increased tumor growth and invasiveness in vivo. Moreover, neutralizing antibodies to CCL20 inhibit the in vivo growth of tumors that either overexpress CXCR4 or CCL20 or naturally express CCL20. These results reveal a role for CCL20 in CXCR4-dependent and -independent tumor growth and suggest a therapeutic potential for CCL20 and CCR6 antagonists in the treatment of CXCR4- and CCL20-dependent malignancies

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2001). A possible role for CXCR4 and its ligand, the CXC chemokine stromal cellderived factor-1, in the development of bone marrow metastases in neuroblastoma.
  2. (2005). Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/ CXCR4-mediated migration of epitheloid carcinoma cells.
  3. (2003). Chemokine biology in cancer.
  4. (2008). Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer.
  5. (2003). Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.
  6. (2001). Chemokines and the molecular basis of cancer metastasis.
  7. (2003). Chemokines integrate JAK/STAT and G-protein pathways during chemotaxis and calcium flux responses.
  8. (2000). Chemokines: a new classification system and their role in immunity.
  9. (1999). Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.
  10. (2002). CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.
  11. (1999). Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and itsCCR6 receptor in human pancreatic cancer.Int
  12. (2006). Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
  13. (2001). Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.
  14. (2000). Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.
  15. (2007). Functional MR imaging during hypercapnia and hyperoxia: noninvasive tool for monitoring changes in liver perfusion and hemodynamics in a rat model.
  16. (1999). In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.
  17. (2002). Induction of macrophage-inflammatory protein-3alpha gene expression by TNF-dependent NF-kappaB activation.
  18. (2006). Involvement of chemokine receptor CCR6 in colorectal cancer metastasis.
  19. (2001). Involvement of chemokine receptors in breast cancer metastasis.
  20. (2001). Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells.
  21. (2000). Localization of distinct Peyer’s patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine.
  22. (1999). Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells.
  23. (2000). Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.
  24. (2007). MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
  25. (2004). MIP3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity.
  26. (1997). Molecular cloning of a novel human CC chemokine liver and activationregulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2.
  27. (2000). Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL6, induce human beta-defensin-2 in respiratory epithelia.
  28. (2006). Role of CXCR3 carboxyl terminus and third intracellular loop in receptormediated migration, adhesion and internalization in response to CXCL11.
  29. (2004). Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
  30. (1999). Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans.
  31. (1998). Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.
  32. (2005). Silencing of CXCR4 blocks breast cancer metastasis.
  33. (2005). Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
  34. (2003). Stromal cellderived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt.
  35. (1998). The alphachemokine, stromal cell-derived factor-1alpha, binds to the transmembrane Gprotein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.
  36. (2004). The significance of cancer cell expression of the chemokine receptor CXCR4.
  37. (2004). Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling.
  38. (2002). Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
  39. (2002). Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.